Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) EBT (2018 - 2025)

Evolus (EOLS) has disclosed EBT for 8 consecutive years, with $515000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 108.11% year-over-year to $515000.0, compared with a TTM value of -$51.0 million through Dec 2025, down 2.43%, and an annual FY2025 reading of -$51.0 million, down 2.43% over the prior year.
  • EBT was $515000.0 for Q4 2025 at Evolus, up from -$15.6 million in the prior quarter.
  • Across five years, EBT topped out at $6.4 million in Q1 2021 and bottomed at -$23.4 million in Q2 2022.
  • Average EBT over 5 years is -$14.2 million, with a median of -$16.2 million recorded in 2021.
  • The sharpest move saw EBT surged 132.92% in 2021, then tumbled 372.93% in 2022.
  • Year by year, EBT stood at -$18.2 million in 2021, then rose by 27.82% to -$13.1 million in 2022, then rose by 10.54% to -$11.7 million in 2023, then surged by 45.83% to -$6.4 million in 2024, then skyrocketed by 108.11% to $515000.0 in 2025.
  • Business Quant data shows EBT for EOLS at $515000.0 in Q4 2025, -$15.6 million in Q3 2025, and -$17.1 million in Q2 2025.